Publications

5674 Results

Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. PMID 20332306; PMC2853720

Authors
A Hoque;C Ambrosone;P Goodman;C Tangen;A Kristal;MS Lucia;Q Wang;M Kappil;I Thompson;A Hsing;H Parnes;RM Santella
Journal / Conference
Cancer Prevention Research 3(4):478-483
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Diet, supplement use, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID20693267;PMC2950820

Authors
A Kristal;K Arnold;ML Neuhouser;P Goodman;D Albanes;IM Thompson
Journal / Conference
American Journal of Epidemiology 172(5):566-577
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Editorial Comment

Authors
IM Thompson
Journal / Conference
Urology 75(3):509-510
Year
2010
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Prognostic impact of monosomal karyotype in young adults and elderly acute myeloid leukemia: the Southwest Oncology Group experience [PMID: 20562328; NIHMSID244631]

Authors
BC Medeiros;M Othus;M Fang;D Roulston;FR Appelbaum
Journal / Conference
Blood 116(13):2224-2228
Year
2010
Research Committee(s)
Leukemia
PMID
PMID20562328
PMC
PMC3709629
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Arsenic trioxide improves event-free and over-all survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710 [PMID20705755; PMC2981533]

Authors
BL Powell;B Moser;W Stock;W Gallagher;C Willman;RM Stone;JM Rowe;S Coutre;JH Feusner;J Gregory;S Couban;FR Appelbaum;MS Tallman;RA Larson
Journal / Conference
Blood 116(10):3751-3757
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
C9710

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling[PMC2924229; PMID20421449]

Authors
E Hartmann;E Campo;G Wright;G Lenz;I Salaverria;P Jares;W Xiao;R Braziel;L Rimsza;W-C Chan;T Weisenburger;J Delabie;E Jaffe;R Gascoyne;S Dave;H-K Mueller-Hermelink;LM Staudt;G Ott;S Bea;A Rosenwald
Journal / Conference
Blood 116(6):953-961
Year
2010
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)

Authors
R Advani;H Chen;V Morrison;E Weller;RI Fisher;B Peterson;R Gascoyne;S Horning
Journal / Conference
British Journal of Haematology 151(2):143-151
Year
2010
Research Committee(s)
Lymphoma
PMID
PMID20735398
PMC
PMC3615251
Study Number(s)
E4494

A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program PMID20682918;PMC2935476

Authors
JF Scoggins;SD Ramsey
Journal / Conference
Journal of the National Cancer Institute 102(17):1371
Year
2010
Research Committee(s)
Outcomes and Comparative Effectiveness

Prolonged administration of Azacitidine with or without Entinostat increases rate of hematologic normalization for myelodysplastic syndrome and acute myeloid leukemia with trilineage cysplasia: results of the E1905 trial

Authors
T Prebet;S Gore;Z Sun;P Greenberg;M Juckett;L Malick;M Smith;E Paietta;M Czader;J Gabrilove;H Erba;M Tallman
Journal / Conference
Blood 116:abst.#1038; American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
E1905

A 10 day schedule of azacitidine induces more complete cytogenetic remissions than the standard schedule: results of the E1905 study

Authors
T Prebet;Z Sun;R Ketterling;G Hicks;CL Beach;P Greenberg;E Paietta;M Czader;J Gabrilove;H Erba;M Tallman;S Gore
Journal / Conference
Blood 116:abst. #601; American Society of Hematology 2010 Annual Meeting; oral
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
E1905